https://pharmadog.xyz/news/476787 pharmadog en 2026-09-30T12:36:54.000Z BioNTech to shut three German manufacturing sites after failing to secure buyers, risking 1,860 jobs https://pharmadog.xyz/news/476639 pharmadog en 2026-09-30T11:59:12.000Z Pennsylvania reports four measles deaths this year, CDC records only two https://pharmadog.xyz/news/134233 pharmadog en 2026-09-30T11:39:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/123087 pharmadog en 2026-09-30T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/476487 pharmadog en 2026-09-30T11:07:16.000Z Ned Sharpless joins Hatteras Venture Partners as managing director, Andrew Witty returns as chairman https://pharmadog.xyz/news/476343 pharmadog en 2026-09-30T10:07:52.000Z AstraZeneca invests $2 billion in Summit Therapeutics as uniQure shares tumble on disappointing Huntington’s data https://pharmadog.xyz/news/476027 pharmadog en 2026-09-30T08:30:00.000Z US must strengthen its biotech sector to stay ahead of China, authors argue https://pharmadog.xyz/news/476029 pharmadog en 2026-09-30T08:30:00.000Z Researchers create mouse with human-derived brain cortex, sparking ethical and scientific debate https://pharmadog.xyz/news/476028 pharmadog en 2026-09-30T08:30:00.000Z Experts call for regulation of kratom and potent 7-OH products, debate over specific rules https://pharmadog.xyz/news/476738 pharmadog en 2026-09-30T08:18:00.000Z VertigoDx receives FDA 510(k) clearance for its portable SmartVertigo diagnostic system https://pharmadog.xyz/news/475371 pharmadog en 2026-09-30T05:00:30.000Z Merck reports positive mid-stage results for Prometheus' tulisokibart in painful skin disease https://pharmadog.xyz/news/476126 pharmadog en 2026-09-30T04:57:00.000Z Mid-dose petrelintide shows strongest weight loss in phase-2 trial, paving way for pivotal study https://pharmadog.xyz/news/476127 pharmadog en 2026-09-30T04:27:00.000Z Amgen's daxdilimab shows 6-point CLASI-A reduction in phase 2 lupus trial https://pharmadog.xyz/news/475227 pharmadog en 2026-09-30T04:02:00.000Z Bicara CEO Claire Mazumdar to step down, COO Ryan Cohlhepp to assume leadership in 2027 https://pharmadog.xyz/news/475228 pharmadog en 2026-09-30T04:02:00.000Z Women-led biotech M&A drops sharply in 2026, only two major deals recorded so far https://pharmadog.xyz/news/475229 pharmadog en 2026-09-30T04:01:00.000Z Biopharma must incentivize scientists to make early go-no-go decisions https://pharmadog.xyz/news/475790 pharmadog en 2026-09-30T03:06:00.000Z Eli Lilly's retatrutide shows over a third of patients lose 25%+ weight in phase 3 trial https://pharmadog.xyz/news/474131 pharmadog en 2026-09-29T22:46:45.000Z MAHA Summit Shows Grassroots Health Movement Aligning with Industry Leaders https://pharmadog.xyz/news/474087 pharmadog en 2026-09-29T22:01:52.000Z Zealand and Roche's amylin analog shows modest weight loss at middle dose, lagging behind Lilly's in Phase 2 trial https://pharmadog.xyz/news/474088 pharmadog en 2026-09-29T22:01:10.000Z Lilly's triple-agonist retatrutide drives up to 18.8% weight loss, over half of patients fall below obesity threshold https://pharmadog.xyz/news/474170 pharmadog en 2026-09-29T21:01:07.000Z US charges two Indian nationals in counterfeit Ozempic distribution scheme https://pharmadog.xyz/news/473687 pharmadog en 2026-09-29T20:41:40.000Z Lawmakers ask Trump to reconsider rule that would tighten import of prescription drugs from Canada https://pharmadog.xyz/news/473499 pharmadog en 2026-09-29T19:37:50.000Z SK pharmteco hosts webinar on overcoming ADC linker-payload manufacturing challenges https://pharmadog.xyz/news/473475 pharmadog en 2026-09-29T19:05:29.000Z Beam Therapeutics sues Chinese scientists and firms YolTech, Serapha Bio over alleged gene-editing technology theft https://pharmadog.xyz/news/473371 pharmadog en 2026-09-29T18:34:00.000Z Beam Therapeutics sues YolTech and Serapha Bio over alleged theft of base editing trade secrets https://pharmadog.xyz/news/473184 pharmadog en 2026-09-29T17:54:41.000Z Beam Therapeutics sues former scientist over alleged IP theft to launch Chinese biotech YolTech https://pharmadog.xyz/news/473139 pharmadog en 2026-09-29T17:00:06.000Z PhRMA appoints former House Majority Leader Eric Cantor as new president and CEO https://pharmadog.xyz/news/473015 pharmadog en 2026-09-29T16:14:43.000Z FDA nominee Heidi Overton’s confirmation won’t be voted on before the midterm elections https://pharmadog.xyz/news/472779 pharmadog en 2026-09-29T15:52:00.000Z Novo to pay Hengrui up to $2.6 billion for rights to weekly obesity pill HRS-1596 https://pharmadog.xyz/news/472715 pharmadog en 2026-09-29T15:15:18.000Z SK pharmteco commits over $200 million to expand CDMO infrastructure, adding 100 jobs over five years https://pharmadog.xyz/news/473450 pharmadog en 2026-09-29T15:05:00.000Z Ontario launches $5M QuickStart program to cut clinical trial start-up time to 45 days https://pharmadog.xyz/news/472547 pharmadog en 2026-09-29T14:46:04.000Z Ascletis pursues oral IL-17A inhibitor for psoriasis as Invivyd readies COVID-19 filing https://pharmadog.xyz/news/472591 pharmadog en 2026-09-29T14:32:24.000Z Anthropic joins ARPA‑H clinical AI moonshot and will host a closed‑door health‑care event https://pharmadog.xyz/news/472548 pharmadog en 2026-09-29T14:23:49.000Z UniQure shares tumble as Huntington's gene therapy shows reduced benefit over time https://pharmadog.xyz/news/472571 pharmadog en 2026-09-29T14:13:37.000Z Roche drops anti-myostatin obesity drug after mid-stage trial shows limited weight loss https://pharmadog.xyz/news/472549 pharmadog en 2026-09-29T14:11:43.000Z Oura cancels planned IPO citing market uncertainty despite strong demand https://pharmadog.xyz/news/472423 pharmadog en 2026-09-29T13:52:51.000Z AstraZeneca commits $2 billion to partner Summit Therapeutics on bispecific cancer antibody https://pharmadog.xyz/news/472403 pharmadog en 2026-09-29T13:45:07.000Z AstraZeneca invests $2 billion in Summit Therapeutics to fund Phase 3 trials of ivonescimab https://pharmadog.xyz/news/472424 pharmadog en 2026-09-29T13:25:06.000Z Novo to pay up to $2.6 billion for rights to Hengrui’s experimental weekly obesity pill https://pharmadog.xyz/news/473114 pharmadog en 2026-09-29T13:22:00.000Z Enanta cuts 37 jobs as it pivots toward immunology and awaits key antiviral trial readouts https://pharmadog.xyz/news/472379 pharmadog en 2026-09-29T13:16:55.000Z ARCH Venture Partners and Population Health Partners launch China-based sleep-disorder startup Somnivera https://pharmadog.xyz/news/472380 pharmadog en 2026-09-29T13:00:58.000Z Fresenius Kabi partners with Waltz Health to sell biosimilars directly to employer health plans https://pharmadog.xyz/news/472381 pharmadog en 2026-09-29T13:00:49.000Z Former Spark co-founder Steven Altschuler launches new immune-resetting biotech https://pharmadog.xyz/news/472443 pharmadog en 2026-09-29T13:00:00.000Z ai3Bio raises $48 million to develop T-helper cell-targeted immune-reset therapies https://pharmadog.xyz/news/472275 pharmadog en 2026-09-29T12:49:00.000Z AstraZeneca puts $2 billion into Summit Therapeutics and partners to test ivonescimab with its oncology pipeline https://pharmadog.xyz/news/472235 pharmadog en 2026-09-29T12:33:27.000Z Novo Nordisk licenses weekly oral obesity peptide from Hengrui in up to $2.6 billion deal https://pharmadog.xyz/news/472255 pharmadog en 2026-09-29T12:02:41.000Z Study finds blocking T cells entry into brain slows neurodegeneration in mice https://pharmadog.xyz/news/472043 pharmadog en 2026-09-29T11:45:14.000Z AI health startup Ortet launches with $500M backing from former Genentech AI team https://pharmadog.xyz/news/472087 pharmadog en 2026-09-29T11:05:00.000Z UniQure’s gene therapy still slows Huntington’s disease after four years, but benefit declines https://pharmadog.xyz/news/472044 pharmadog en 2026-09-29T11:04:17.000Z Novo pays $300 million upfront to license Hengrui’s weekly oral GLP-1/GIP weight-loss drug https://pharmadog.xyz/news/472045 pharmadog en 2026-09-29T11:00:34.000Z Swedish biotech AnaCardio secures $70.9M Series B to advance heart failure drug https://pharmadog.xyz/news/471875 pharmadog en 2026-09-29T10:28:58.000Z BioNTech to shut three German manufacturing sites after sale talks fall through https://pharmadog.xyz/news/472522 pharmadog en 2026-09-29T09:29:00.000Z uniQure shares tumble 41% after Huntington’s gene therapy misses primary endpoint https://pharmadog.xyz/news/471480 pharmadog en 2026-09-29T08:30:00.000Z SNAP cuts risk increasing child separations, advocates warn https://pharmadog.xyz/news/471478 pharmadog en 2026-09-29T08:30:00.000Z Midterm elections could reshape drug pricing, Medicaid funding and research support, industry leaders warn https://pharmadog.xyz/news/471477 pharmadog en 2026-09-29T08:30:00.000Z CMS ends automatic Medicare bonuses for FDA breakthrough devices https://pharmadog.xyz/news/471479 pharmadog en 2026-09-29T08:30:00.000Z Child health crisis threatens US national security, authors warn https://pharmadog.xyz/news/471476 pharmadog en 2026-09-29T08:30:00.000Z Sociologist finds vaccine-hesitant parents make logical choices, not anti-science https://pharmadog.xyz/news/471475 pharmadog en 2026-09-29T08:30:00.000Z MAHA Institute pushes for broader health data sharing to aid research on chronic disease and autism https://pharmadog.xyz/news/471119 pharmadog en 2026-09-29T06:00:00.000Z Curium gains FDA nod for Bexlutry as it eyes challenge to Novartis radioligand therapies https://pharmadog.xyz/news/471574 pharmadog en 2026-09-29T03:51:00.000Z Novo Nordisk signs $2.6 billion deal with China's Hengrui for oral GLP-1/GIP candidate https://pharmadog.xyz/news/471406 pharmadog en 2026-09-29T03:07:00.000Z AstraZeneca invests $2 billion in Summit Therapeutics to advance PD-1xVEGF bispecific ivonescimab with ADC combos https://pharmadog.xyz/news/469979 pharmadog en 2026-09-29T00:47:27.000Z FDA approves Egetis Therapeutics' Emcitate for rare X linked disease shortening life expectancy to 35 years https://pharmadog.xyz/news/474161 pharmadog en 2026-09-29T00:00:00.000Z FDA releases draft guidance on requirements for robotically assisted surgical devices https://pharmadog.xyz/news/473549 pharmadog en 2026-09-29T00:00:00.000Z FDA approves Egetis’ Emcitate for rare genetic disease as Novo secures Chinese weight-loss pill in $2.6 billion deal https://pharmadog.xyz/news/474162 pharmadog en 2026-09-29T00:00:00.000Z Regulators Discuss Plans to Streamline Europe’s Drug Approval Process at 2026 RAPS Convergence https://pharmadog.xyz/news/469535 pharmadog en 2026-09-28T22:22:39.000Z AstraZeneca invests $2 billion for stake in Summit Therapeutics to back its cancer drug https://pharmadog.xyz/news/469618 pharmadog en 2026-09-28T21:43:18.000Z FDA approves Emcitate for peripheral thyrotoxicosis in patients with MCT8 deficiency https://pharmadog.xyz/news/469411 pharmadog en 2026-09-28T21:07:09.000Z Study finds toxic metal exposure persists months after Maui wildfires https://pharmadog.xyz/news/469619 pharmadog en 2026-09-28T21:00:01.000Z FDA to review and potentially overhaul PMTA rules amid lawsuit and illicit market concerns https://pharmadog.xyz/news/469243 pharmadog en 2026-09-28T20:45:43.000Z Merck pulls Recarbrio antibiotic from U.S. market, raising concerns over superbug resistance https://pharmadog.xyz/news/469031 pharmadog en 2026-09-28T19:01:13.000Z Adicet Bio reports early CAR-T therapy improves lupus symptoms, plans pivotal trial as shares fall https://pharmadog.xyz/news/468863 pharmadog en 2026-09-28T18:50:33.000Z Mirum reports Phase 3 success for its acquired hepatitis D therapy https://pharmadog.xyz/news/468651 pharmadog en 2026-09-28T17:55:51.000Z Trump administration seeks Supreme Court stay on gender-affirming care restrictions in federal prisons https://pharmadog.xyz/news/468607 pharmadog en 2026-09-28T17:41:21.000Z White House seeks data on U.S. manufacturing of 86 essential medicines https://pharmadog.xyz/news/472354 pharmadog en 2026-09-28T16:25:00.000Z ai3Bio raises $48 million to develop T-cell targeting therapy for autoimmune disease https://pharmadog.xyz/news/468503 pharmadog en 2026-09-28T16:11:00.000Z Kodiak Sciences' Phase 3 eye drug data beats Regeneron’s Eylea, shares double https://pharmadog.xyz/news/468504 pharmadog en 2026-09-28T15:52:00.000Z Adicet's off-the-shelf CAR-T shows 50% kidney response in early lupus trial https://pharmadog.xyz/news/468271 pharmadog en 2026-09-28T15:45:19.000Z Nonprofits launch ultra-rare immune disease gene therapy Waskyra at $3.25 million price https://pharmadog.xyz/news/468272 pharmadog en 2026-09-28T15:22:04.000Z Scynexis secures $200M+ BARDA contract for investigational antifungal SCY-247 https://pharmadog.xyz/news/468273 pharmadog en 2026-09-28T15:19:38.000Z Kodiak Sciences reports Phase 3 success for Zenkuda, matching Eylea in wet AMD https://pharmadog.xyz/news/468295 pharmadog en 2026-09-28T15:11:01.000Z Kodiak Sciences' zenkuda and tabirafusp-ted match Eylea in Phase 3, sending stock up 166% https://pharmadog.xyz/news/468147 pharmadog en 2026-09-28T14:55:21.000Z Rising health insurance premiums and a private equity hospital chain's shift to nonprofit highlight bleak outlook for US healthcare costs https://pharmadog.xyz/news/472670 pharmadog en 2026-09-28T14:26:00.000Z Sierra Nevada Cheese Company recalls all Graziers raw milk cheeses over possible E. coli O26:H11 contamination